Press Releases Year None2023202220212020201920182017 Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting June 5, 2023 PDF Version READ MORE Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments May 10, 2023 PDF Version READ MORE Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting April 26, 2023 PDF Version READ MORE Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference April 13, 2023 PDF Version READ MORE Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update March 29, 2023 PDF Version READ MORE Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023 March 23, 2023 PDF Version READ MORE Atreca to Participate at Cowen’s 43rd Annual Health Care Conference March 1, 2023 PDF Version READ MORE Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target February 6, 2023 PDF Version READ MORE Atreca Appoints Philippe Bishop, MD as Chief Medical Officer January 9, 2023 PDF Version READ MORE
